Y-mAbs reported DANYELZA net product revenues of $20.8 million for the quarter ended June 30, 2023, representing an increase of 112% over the comparable period of 2022. The company's cash and cash equivalents are expected to support operations into 2026.
DANYELZA net product revenues increased by 112% compared to the same quarter last year.
International revenues included $3.5 million from a China commercial launch inventory stocking order.
DANYELZA has been delivered to 56 centers across the U.S., a sequential increase of 6% since the first quarter of 2023.
Net loss for the second quarter ended June 30, 2023, was $6.3 million, compared to a net loss of $41.1 million for the quarter ended June 30, 2022.
Management reiterates its full year 2023 financial guidance, as updated on May 8, 2023.
Analyze how earnings announcements historically affect stock price performance